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Sevoflurane is widely used in adult and pediatric patients during clinical surgeries.
Although studies have shown that exposure to sevoflurane impairs solfactory memory
after an operation, the neuropathological changes underlying this effect are not clear.
This study detected the effect of sevoflurane exposure on the development of calcium-
binding proteins-expressing interneurons in the main olfactory bulb (MOB). We exposed
neonatal mice to 2% sevoflurane at two different developmental time points and found
that exposing mice to sevoflurane at postnatal day (PD) 7 significantly decreased the
expression of GAD67 and parvalbumin (PV) in the olfactory bulb (OB) but did not alter
the expression of calretinin (CR) or calbindin D28k (CB). The number and dendritic
morphology of PV-expressing interneurons in the MOB were impaired by exposure
to sevoflurane at PD7. However, exposure to sevoflurane at PD10 had no effect on
calcium-binding protein expression or the number and dendritic morphology of PV-
expressing interneurons in the MOB. These results suggest that exposing neonatal mice
to sevoflurane during a critical period of olfactory development affects the development
of PV-expressing interneurons in the MOB.
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INTRODUCTION
Inhalation anesthetics are widely used in adult and pediatric patients during surgeries, and
sevoflurane is one of the most frequently used inhalation anesthetics in infants and children
because it has a low blood/gas ratio, low pungency and a rapid onset and recovery (Sakai et al.,
2005; Edwards et al., 2010; Gibert et al., 2012). However, animal studies have shown that exposing
animals to inhalation anesthetics during critical developmental periods can induce neuropathologic
changes and impair cognitive functions (Culley et al., 2003, 2004; Jevtovic-Todorovic et al.,
2003; Fredriksson et al., 2007; Rammes et al., 2009). Sevoflurane was shown to induce neuronal
Abbreviations: CB, calbindinD28k; CR, calretinin; ECL, chemiluminescence; EPL, external plexiform layer;
GABA, γ-aminobutyric acid; GCL, glomerular cell layer; GL, glomerular layer; MOB, main olfactory bulb;
PD, postnatal days; PV, parvalbumin; PVDF, polyvinylidenedifluoride.
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apoptosis and neuroinflammation and to inhibit neurogenesis
in neonatal mice (Lu et al., 2010; Nie et al., 2013; Shen et al.,
2013; Zhang et al., 2013). Exposing young rats to sevoflurane
altered dendritic spine density during an important stage in
synapse formation (Briner et al., 2010). These discoveries
indicate that exposure to sevoflurane can affect the normal
development of the brain. The olfactory system is vulnerable to
volatile agents because its receptors are directly exposed to the
outside environment. Although studies have shown that inhaling
anesthetic drugs can lead to olfactory dysfunction (Adelman,
1995; Fukumoto et al., 2005), there are few reports showing
the neuropathologic changes in olfactory system induced by
sevoflurane exposure.
The olfactory system consists of the olfactory epithelium,
the main olfactory bulb (MOB) and the olfactory cortex.
The MOB is an important part of the olfactory system for
olfactory functions. It has high plasticity because its neural
network can be modified even by simple stimulation during
an olfactory experience, such as exposure to an odorant
(Buonviso et al., 1998; Buonviso and Chaput, 2000). The
interneurons are the main population of neurons in the MOB,
and they are even more sensitive to environmental stimulation
because they have a prolonged developmental period and
a highly dynamic nature, with continuous genesis occurring
during the postnatal and adult periods (Altman, 1969; Lledo
et al., 2004). Studies have shown that inducing early postnatal
deprivation with uninaris occlusion can decrease the number
of granule cells in the MOB and affect their maturation
(Frazier-Cierpial and Brunjes, 1989; Brunjes, 1994). Olfactory
enrichment can promote the survival of interneurons in the
MOB during postnatal development (Mandairon et al., 2008).
These discoveries demonstrated that sensory activity is essential
for the normal development of interneurons in the MOB.
No reports have shown whether inhaling anesthetic drugs
affects neurons in the MOB in developing mice. In this study,
we aimed to examine the effects of sevoflurane exposure on
interneurons in the MOB of mice at different developmental
stages.
Interneurons in the MOB use γ-aminobutyric acid (GABA)
as their main neurotransmitter (Groh et al., 2004) and can
be distinguished by their expression of different calcium-
binding proteins, such as calretinin (CR), parvalbumin (PV),
and calbindin D28k (CB; Parrish-Aungst et al., 2007). The
CR-expressing neurons are scattered in the glomerular layer
(GL), external plexiform layer (EPL) and granule cell layer
(GCL) of the MOB, while CB-expressing neurons are mainly
concentrated in the GL (Baimbridge et al., 1982; Hendrickson
et al., 1991; Kiraly and Celio, 1991; Kosaka et al., 1995). PV-
expressing neurons are mainly located in the EPL (Kosaka
et al., 1987, 1994; Crespo et al., 1999; Hwang et al., 2003).
These neurons form the main inhibitory circuits in the
MOB, and changes in the expression of these calcium-
binding proteins can define the functional characteristics of
interneurons and impact olfactory functions. To investigate
whether sevoflurane exposure during early postnatal life affects
the later development of these neurons, we exposed neonatal
mice to clinically relevant concentrations of sevoflurane (2%)
for 6 h as used in the study of Yufune et al. (2016) at
two distinct developmental stages in the MOB: postnatal days
(PD) 7 and 10. We found that sevoflurane exposure at PD7
decreased the number of PV-expressing neurons and affected
their dendritic development. CR- and CB-expressing neurons
were not affected by sevoflurane exposure at either PD7
or PD10.
MATERIALS AND METHODS
Experimental Animals
C57BL/6 mice were purchased from the Experimental
Animal Center of the Fourth Military Medical University
and individually housed with free access to food and water
in a temperature- and humidity-controlled environment with
a 12:12 h light/dark cycle. When the neonatal mice reached
PD7 or PD10, the treatments were performed. All experimental
procedures received prior approval from the Animal Use and
Care Committee for Research and Education of the Fourth
Military Medical University (Xi’an, China). Every effort was
taken to minimize animal suffering and to reduce the number of
animals used. A total of 12 liters containing 102 male offspring
were used in this study.
Anesthesia Treatment
When the pups reached PD7 or PD10, they were randomly
divided into a sevoflurane-treated group and an air-treated
control group. Mice in the sevoflurane-treated group were
placed in a plastic container and continuously exposed to 2%
sevoflurane for 6 h using air as a carrier with a gas flow of
2 liters/min. During sevoflurane exposure, the container was
heated to 38◦C. The control animals were exposed to air without
sevoflurane. After 6 h of treatment, the pups were placed back
into their maternal cages.
Nissl Staining
For nissl staining, mice at PD14, PD28 and PD42 in each group
were deeply anesthetized with sodium pentobarbital (50 mg/kg)
and then perfused with 20 mL 0.01 M phosphate-buffered saline
(PBS, pH = 7.4), followed by 100 mL 4% paraformaldehyde
in 0.1 M phosphate buffer solution (PB, pH = 7.4). Then the
Olfactory Bulbs (OB) were removed and post-fixed in the same
fixative for 3 h and then cryoprotected for 24 h at 4◦C in 0.1 M
PB containing 30% sucrose. Coronal sections (30 µm) were cut
in a freezing microtome (Leica CM1800, Heidelberg, Germany)
at −20◦C and collected in 0.01 M PBS. For staining, the sections
were mounted on gelatin coated glass slides. When dried, the
sections were defatted in 75% ethanol at 37◦C overnight. Then
the sections were stained for 10 min in 0.1% cresyl violet solution
at RT, after rinsing with water, sections were incubated with 70%
ethanol (3 s), 80% ethanol (3 s), 90% ethanol (3 s), 95% ethanol
(3 s), absolute ethanol I (3 s) and absolute ethanol II (5 min)
and then with xylene I (10 min) and xylene II (30 min). Sections
were observed under an optical microscope after mounting with
permount.
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Western Blot Analysis
When pups reached their ages, they were sacrificed, and
the olfactory were rapidly removed. The tissue samples were
homogenized using an ultrasonic wave (10 s, 3 times) in
RIPA lysis buffer, which contained a cocktail of proteinase
and phosphatase inhibitors (Roche). After centrifugation at
12,000 rpm for 15 min at 4◦C, the protein-containing
supernatants were collected. The protein concentrations were
determined with a BCA-based kit (Pierce). Lysate samples
were subjected to sodium dodecyl sulfate polyacrylamide
gel electrophoresis; then, the proteins were transferred onto
polyvinylidenedifluoride (PVDF) membranes (Bio-Rad). After
blocked with 5% defatted milk in Tween/Tris-buffered saline
(TBST) for 1 h at room temperature, the membranes were
incubated with the primary antibody at 4◦C overnight. The
following primary antibodies were used: mouse monoclonal
GAD67 (Chemiconr 1:5000), mouse monoclonal CB (Sigma-
Aldrich 1:1000), goat polyclonal CR (Abcam 1:2000), rabbit
polyclonal PV (Abcam 1:1000) and mouse polyclonal β-actin
(Sigma-Aldrich 1:5000). After washing in TBST, the membranes
were incubated in a secondary antibody for 2 h at room
temperature. All of the blots were detected by an enhanced
chemiluminescence (ECL) detection system (Advansta). The
scanned images were quantified with ImageJ (version 1.47)
Software.
Immunofluorescence Staining and Cell
Counting
The mice atPD42 in each group were deeply anesthetized with a
lethal dose of sodium pentobarbital (50 mg/kg of body weight)
and then perfused with 0.01 M PBS (pH 7.4), followed by a
4% phosphate-buffered formalin in a 0.1 M phosphate buffer
solution (pH 7.4). Coronal olfactory sections (30 µm) were cut
in a freezing microtome (Leica CM1800, Heidelberg, Germany)
at −20◦C and collected in 0.01 M PBS. During the staining,
the cryostated sections were washed in PBS three times, and
following blocking in 10% normal donkey serum in PBS, the
sections were incubated with primary antibodies overnight at
4◦C. The following antibodies were used: mouse monoclonal
CB (Sigma-Aldrich 1:500), goat polyclonal CR (Abcam 1:1000),
and rabbit polyclonal PV (Abcam 1:500). After rinsing in PBS,
the slides were incubated with secondary antibodies conjugated
with Alexa Fluor 488 (Invitrogen/Life Technologies 1:500) for
2 h at room temperature and counterstained with 100 ng/ml
DAPI. After rinsing in PBS, the sections were mounted on
gelatin-coated glass slides and cover slipped in Flouromount G.
The sections were observed and captured with a confocal laser
scanning microscope (Olympus FV1000, Japan). Imaging-Pro-
Plus (LEIKADMLB) was used to perform quantitative analysis of
the positive immunostained cells numbers. Every fourth coronal
section through the OB was collected, and a total of five sections
from each mouse were used for quantification. The number
of immunostained cells in each field was counted at a higher
magnification (200×). Three random fields were captured in
each section, and the mean number of immunostained neurons
per view in the three views was included as the data for each
section. The final average number of immunostained neurons
per vision in all sections was included as the data for each
sample.
Statistic Analysis
All data were presented as Mean ± SD. The statistical analysis
was performed with GraphPad Prism 5.0 Software (GraphPad
Software) and comparisons of the means of two groups were
performed using the Student t test. Statistical significance was
inferred at P < 0.05.
RESULTS
Effects of Sevoflurane Exposure at PD7
and 10 on the Laminar Organization
of the MOB
To explore the effect of sevoflurane exposure on the overall
morphology of the MOB, Nissl staining was used to show
the structure of the MOB. A distinct laminar organization
can be seen in the MOB, with intact glomeruli and clear
layers. Following sevoflurane exposure at PD7 and PD10, the
organization of the MOB was the same as that in control mice
(Figure 1).
Changes in the Expression of GAD67
and Calcium-Binding Proteins in the OB
of Mice Exposed to Sevoflurane at PD7
To assess the effect of sevoflurane exposure at PD7 on
interneurons in the OB at different developmental stages, we
first analyzed GAD67 expression in the OB in the sevoflurane-
treated mice and control mice at PD14, 28 and 42 using western
blot analysis. Compared to the control group, the expression
of GAD67 was significantly decreased at PD14, 28 and 42 in
the OB in the sevoflurane-treated mice. The significance of
this difference was decreased as the age of the mice increased
(Figures 2A,B; P = 0.0001 at PD14, P = 0.000477 at PD28,
and P = 0.00156 at PD42). To explore which subtypes of
interneurons were affected, the expression of calcium-binding
proteins was analyzed using western blot analysis. Compared
to control mice, sevoflurane exposure at PD7 significantly
decreased the expression of PV in the OB of mice when
analyzed at PD14, 28 and 42 (Figures 2A,C; P < 0.001
at PD14 and 28, P < 0.01 at PD42). However, there were
no significant differences in the expression of CB and CR
between the sevoflurane-treated mice and the control mice
(Figures 2A,D,E).
Effects of Sevoflurane Exposure at PD7
on the Number of Calcium-Binding
Protein-Expressing Neurons in the MOB
To determine whether the observed molecular changes
represented alterations at the cellular level, immunofluorescence
staining was performed to display calcium-binding proteins in
immunoreactive (ir) interneurons. The pattern of distribution
for PV-ir, CR-ir and CB-ir interneurons were not qualitatively
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FIGURE 1 | The effect of exposure to sevoflurane at postnatal days 7 (PD7) and 10 (PD10) on the laminar organization of main olfactory bulb (MOB).
No significant change in the laminar organization of the MOB was observed between control mice (A) and mice exposed to sevoflurane at PD7 (B). Compared to
control MOBs (C), the laminar organization of the MOB in mice that were treated with sevoflurane at PD10 (D) was unchanged. (A1–D1) High magnification images
showing the structure of the MOB. Scale bars = 500 µm in (D) (applies to A–D) and 100 µm in (D1) (applies to A1–D1).
FIGURE 2 | The effect of exposure to sevoflurane at PD7 on GAD67 and calcium-binding protein expression. (A) Representative autoradiogram showing
the expression of GAD67 and calcium-binding proteins in the MOB at PD14, 28 and 42. Normal: control group. SEV: sevoflurane-treated group. Quantitative analysis
of the results of western blot analysis to determine the expression of GAD67 (B), parvalbumin (PV) (C), calretinin (CR) (D), and calbindin D28k (CB) (E) Values are
expressed as the Mean ± SD. ***P < 0.001, **P < 0.01, and *P < 0.05.
different between sevoflurane-treated mice and control mice.
The soma of the PV-ir interneurons were mainly located
in the EPL and few PV-ir cells located in ML and IPL. The
CB-ir interneurons were periglomerular interneurons, and the
CR-ir interneurons were observed in all layers of the MOB,
with the highest packing density in the GL (Figures 3A–F).
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FIGURE 3 | The effect of exposure to sevoflurane at PD7 on the number of calcium-binding protein-expressing neurons in the MOB. Control mice
(A) had more PV interneurons in the MOB than the sevoflurane-treated mice (B). (A1,B1) High magnification images of PV interneurons in the MOB. The density of
CR interneurons in the MOB of mice exposed to sevoflurane at PD7 (D) was unaffected compared to the control mice (E). (D1,E1) High magnification images of CR
interneurons in the MOB. The density of CB interneurons in the MOB of mice exposed to sevoflurane at PD7 (G) was unaffected compared to the control mice (H).
(G1,H1) High magnification images of CB interneurons in the MOB. Normal: control group. SEV: sevoflurane-treated group. Quantification analysis of the number of
PV-ir neurons (C), CR-ir neurons (F) and CB-ir neurons (I) in different layers of MOB. Scale bars = 100 µm (applies to A–H,A1–H1). Values are expressed as the
Mean ± SD. ***P < 0.001.
Quantitative estimations of PV-ir interneuronal density in
the MOB in PD42 mice revealed that sevoflurane exposure
at PD7 significantly decreased the number of PV-ir neurons
not only in EPL but also in the ML and IPL (Figure 3G,
P < 0.001 respectively). However, sevoflurane exposure at PD7
did not induce a striking change in the density of CR-ir and
CB-ir interneurons compared to their numbers in the controls
(Figures 3H,I).
Morphological Alterations
in PV-expressing Interneurons in the MOB
of Mice Exposed to Sevoflurane at PD7
To further evaluate the effect of sevoflurane on neuronal
morphologies, immunofluorescence staining was used to display
the dendritic arbor architecture of these interneurons in control
and sevoflurane-exposed mice at PD42. The results showed
that the PV-ir interneurons in the MOB in control mice
were multipolar neurons with extensive and clear dendrite
complexities with visible secondary and tertiary dendrites
(Figures 4A–B2). In the sevoflurane-treated mice, the dendritic
branches of PV-ir interneurons were significantly decreased,
and some of these neurons had no dendrites (Figures 4D–D2).
Unlike in the PV-expressing neurons, the dendrites of the
CR-ir and CB-ir interneurons were not affected by sevoflurane
exposure at PD7 (Figures 4E–L).
Effects of Sevoflurane Exposure
at PD10 on the Expression of GAD67
and Calcium-Binding Proteins in the OB
in Mice
To further explore the effect of sevoflurane exposure on
phases of OB interneuron development, mice were subjected to
sevoflurane exposure at PD10, and the expression of GAD67
and calcium-binding proteinswas detected using western blot
analysis. At PD14, 28 and 42, there were no significant differences
in the expression of GAD67, PV, CB, and CR in the OB
between control mice and sevoflurane-exposed mice (Figure 5,
P > 0.05).
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FIGURE 4 | The effect of exposure to sevoflurane at PD7 on the dendritic architecture of calcium-binding protein-expressing neurons in the MOB.
Compared to the control group (A,B), the dendritic morphologies of PV interneurons were impaired by exposure to sevoflurane at PD7 (C,D). (B1,B2,D1,D2) High
magnification images of PV interneurons in the MOB. Compared to the control group (E,F), the dendritic morphologies of CR interneurons were not impaired by
exposure to sevoflurane at PD7 (G,H). (F1,F2,H1,H2) High magnification images of CR interneurons in the MOB. Compared to the control group (I,J), the dendritic
morphologies of CB interneurons were not impaired by exposure to sevoflurane at PD7 (K,L). (J1,J2,L1,L2) High magnification images of CR interneurons in the
MOB. Scale bars = 100 µm in (K) (applies to A,C,E,G,I,K), 50 µm in (L) (applies to B,D,F,H,J,L), and 5 µm in (L2) (applies to
B1,B2,D1,D2,F1,F2,H1,H2,J1,J2,L1,L2).
FIGURE 5 | The effect of exposure to sevoflurane at PD10 on GAD67 and calcium-binding protein expression. (A) Representative autoradiogram of
GAD67 and calcium-binding protein expression in the MOB at PD14, 28 and 42. Normal: control group. SEV: sevoflurane-treated group. Quantitative analysis of
western blot results showing the expression of GAD67 (B), PV (C), CB (D), and CR (E). Values are expressed as the Mean ± SD.
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FIGURE 6 | The effect of exposure to sevoflurane at PD10 on the number and dendritic morphology of PV interneurons. Compared to the control group
(A–C), the number and dendritic morphologies of PV interneurons were not impaired by exposure to sevoflurane at PD10 (D–F). (C1,C2,F1,F2) High magnification
images of PV interneurons in the MOB. (G) Quantification analysis of the number of PV-ir neurons in different layers of MOB. Scale bars = 200 µm in (D) (applies to
A,D), 100 µm in (E) (applies to B,E), 50 µm in (F) (applies to C,F), and 5 µm in (F2) (applies to C1,C2,F1,F2). Values are expressed as the Mean ± SD.
Effects of Sevoflurane Exposure at PD10
on the Numbers and Morphologies
of PV-expressing interneurons
To further confirm the effects of sevoflurane exposure at
PD10 on PV-expressing interneurons at the cellular level,
immunofluorescence staining was used to detect the numbers
and morphologies of PV-ir interneurons in the MOB of
control and sevoflurane-treated mice at PD42. No difference
was observed in the number of PV-ir interneurons not only
in EPL but also in the ML and IPL of the MOB between
control mice and sevoflurane-treated mice (Figures 6A,B,D,E,G,
P > 0.05). The dendrites of the PV-ir neurons in the MOB
were clear and ramulose in both the control mice and the
sevoflurane-exposedmice (Figures 6C–C2,F–F2). This indicated
that sevoflurane exposure at PD10 had no effect on the PV-
expressing interneurons of the MOB.
DISCUSSION
In the present study, by exposing neonatal mice to sevoflurane,
we explored the effects of sevoflurane on interneurons in the OB
of developing mice. First, we found that the laminar organization
of the MOB was not adversely affected by sevoflurane exposure
at either PD7 or PD10. Second, sevoflurane exposure at PD7
affected the survival and dendritic development of PV-expressing
interneurons in the MOB. Finally, sevoflurane exposure at
PD10 had no effect on calcium-binding protein-expressing
interneurons in the MOB.
Sevoflurane is one of the most commonly used anesthetics
in neonatal and pediatric patients (Lerman et al., 1994). A
report showed that the perception of smells was altered during
inhalational induction in children (Verschuur et al., 2005). To
explore whether sevoflurane exposure during the early neonatal
period induces neuropathological changes in the olfactory system
for olfactory dysfunctions, the OB was chosen because it is the
first relay station for the transmission of olfactory information
and because it is highly plastic. Recent studies have shown that
there is a critical developmental period for the mammalian
olfactory system (Ma et al., 2014; Tsai and Barnea, 2014). The
discoveries of Tsai and Barnea (2014) and Ma et al. (2014)
demonstrated that the first postnatal week is the critical period
for glomerular map organization in the OB. Meanwhile previous
study demonstrated that immature brains are, in general,
the most vulnerable to anesthesia at PD7 (Yon et al., 2005).
Considering this critical period, we chose two developmental
time points that fell within the early postnatal period. We first
detected the effects of sevoflurane exposure at PD7 and PD10 on
the laminar organization of the MOB at different developmental
stages and found that sevoflurane exposure during the early
postnatal period did not impair the laminar architecture or
volume of the MOB in mice (Figure 1). The clear glomerular
structures of the MOB in mice are developed around PD4, and
their construction can be affected by olfactory activities (Royal
and Key, 1999; Potter et al., 2001; Zou et al., 2004). In some
diseases that are associated with olfactory malfunctions, such as
schizophrenia, patients display a smaller MOB (Turetsky et al.,
2000, 2003). Here, the intact laminar organization of the MOB
may indicate that basic olfactory functions are preserved after
sevoflurane exposure.
A previous report demonstrated that olfactory acuity was
intact in patients after anesthesia with sevoflurane, whereas
olfactory memory was impaired (Kostopanagiotou et al.,
2011). Although the mechanisms underlying this effect are
not understood, previous studies have mainly focused on the
effects of sevoflurane on GABAergic circuits (Bein et al., 2008;
Michel and Constantin, 2009; Kotani and Akaike, 2013). In the
MOB, the ratio of local GABAergic interneurons to excitatory
neurons is 100:1(Groh et al., 2004). These interneurons comprise
the local circuitry in the MOB. In our study, we found the
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expression of GAD67 was decreased in the OB in mice after
sevoflurane exposure at PD7. The most dramatic decrease
in its expression was observed at 1 week after sevoflurane
exposure. This effect was reduced as the age of the mice
increased (Figures 2A,B). In the MOB, most interneurons
express GAD67, and GAD67 is expressed in the soma and
puncta of neurons, where it is responsible for maintaining
baseline levels of GABA (Tsunekawa et al., 2005). The decreased
expression of GAD67 might indicate changes in the numbers
or functions of interneurons in the MOB. Different subtypes
of GABAergic interneurons can be classified by molecular
makers, such as CR, PV and CB (Parrish-Aungst et al., 2007).
These calcium-binding protein-expressing neurons are the main
populations of interneurons in the MOB. The expression of PV
was dramatically reduced in the OB in the animals exposed to
sevoflurane at PD7, and this effect was not reversed as the mice
increased in age (Figures 2A,C). Cell counting was performed
to determine the number of PV-ir interneurons in the MOB
after sevoflurane inhalation at PD7. The results showed that
the number of PV-containing interneurons was significantly
decreased of MOB in the sevoflurane-treated mice at later ages
(Figures 3A,A1,B,B1,G). However, no changes were observed
in the expression of PV or the number of PV-ir neurons in the
mice exposed to sevoflurane at PD10 (Figures 5A–C). It was
widely accepted that sevoflurane exposure induced neuronal
apoptosis in developing brains (Satomoto et al., 2009; Lu
et al., 2010; Fang et al., 2012). A previous study demonstrated
that immature brains are, in general, the most vulnerable to
anesthesia-induced neuro-apoptosis at PD7 (Yon et al., 2005).
Therefore, we concluded that sevoflurane exposure during this
critical period of olfactory development affected the survival of
PV-expressing interneurons in the MOB.
In humans and rodents, postnatal development is also an
important period for the precise formation of neuronal circuits
in the central nervous system (Petit et al., 1988; Brown et al.,
1997; De Felipe et al., 1997). This postnatal period of immense
growth is marked by synaptogenesis, which involves dendritic
branching and the formation of synapses (Micheva and Beaulieu,
1996). The study of De Felipe et al. (1997) showed that in the
rodent cortex inhibitory synaptogenesis begins at early time,
and they find both asymmetrical and symmetrical synapses were
present in all layers from P4. Meanwhile, discovery from the
development of the adult new-born interneurons showed that
GABAergic and glutamatergic synaptic contacts increased at
7 dpi (Panzanelli et al., 2009). Previous studies have shown
that exposure to anesthesia during this phase can affect the
normal development of spines and synapses (Briner et al., 2010;
Lunardi et al., 2010; Amrock et al., 2015). In our study, we
found that exposure to sevoflurane at PD7 decreased dendritic
branches in PV-ir interneurons in the MOB (Figures 4C,D–D2),
whereas sevoflurane exposure at PD10 did not affect dendritic
architecture (Figures 6A–F). These results indicate that exposure
to sevoflurane during peak synaptogenesis affects the normal
development of dendrites in PV neurons in the MOB.
Interneurons in the OB are a heterogeneous population
that is produced beginning in embryogenesis and continuing
through adulthood. The development of different calcium-
binding protein-expressing neurons occurs in a spatially and
temporally regulated manner (Stenman et al., 2003; Waclaw
et al., 2006; Young et al., 2007; Batista-Brito et al., 2008; Li
et al., 2011). Different interneurons are preferentially produced
at different ages. PV-expressing interneurons are produced from
late embryogenesis to early postnatal stages (E17 to P3). After
P5, there is no new production of PV-expressing neurons in the
OB (Li et al., 2011). Although a previous study showed that after
ischemic lesion, progenitors in the SVZ can migrate to the lesion
site and differentiate into mature PV-containing neurons, there
is no evidence that a lesion in the OB can induce the regeneration
of PV interneurons (Teramoto et al., 2003). This may explain
why the loss of PV-expressing interneurons that was induced
by sevoflurane exposure at PD7 was not compensated when the
mice matured. Unlike PV interneurons, CB- and CR-expressing
interneurons can be generated throughout postnatal stages, and
CR-expressing interneurons make up the largest proportion of
neurons that are born in adult mice (Batista-Brito et al., 2008;
Li et al., 2011).In our study, we found that sevoflurane exposure
PD7 or PD10 did not affect the number of CB- andCR-expressing
interneurons in the MOB (Figures 2A,B,E, 5A,D,E). Previous
reports showed that exposing PD4-6 neonatal rats to 1.8%
sevoflurane for 6 h promoted hippocampal neurogenesis (Chen
et al., 2015). Therefore, we assumed that sevoflurane exposure
might promote neurogenesis in the OB, and that this may have
contributed to fact that there was no change in the number of
CB- and CR-expressing interneurons. However, further studies
should be performed to test this assumption.
In conclusion, this study is the first to describe the effect
of sevoflurane exposure at two different developmental time
points on the development of interneurons in the MOB. The
results suggest that in neonatal mice, exposure to 2% sevoflurane
of at PD7 can affect the survival and dendritic development
of PV-expressing interneurons in the MOB, but it does not
affect CB- and CR-expressing interneurons in the MOB. These
findings may lay a morphological foundation for studies aimed
at determining the effects of sevoflurane exposure on olfactory
functions.
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